Scan to Download
One power score. Smarter investment decisions
Acurx Pharmaceuticals Inc
ACXP4.100USD
-0.240-5.53%
Close 09/19, 16:00（ET）Quotes delayed by 15 min
USD0.000After-hours (ET)
301.42KMarket Cap
LossP/E TTM
Acurx Pharmaceuticals Inc
4.100
-0.240-5.53%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2020Q2
FY2020Q1
Operating expenses
-44.94%2.27M
-50.91%2.15M
-45.61%2.78M
-9.42%2.82M
19.64%4.12M
50.81%4.38M
56.86%5.11M
-12.05%3.11M
31.47%3.45M
8.72%2.90M
24.11%3.26M
-23.71%3.54M
-35.62%2.62M
81.11%2.67M
140.35%2.63M
253.14%4.64M
345.67%4.07M
15.26%1.47M
--1.09M
--1.31M
--913.36K
--1.28M
R&D expenses
-71.29%524.21K
-61.49%598.80K
-57.53%825.06K
-11.18%1.20M
5.14%1.83M
53.12%1.56M
35.60%1.94M
-15.21%1.35M
90.46%1.74M
24.02%1.02M
100.03%1.43M
41.18%1.59M
858.93%911.69K
790.99%818.89K
56.54%716.22K
70.76%1.13M
-76.28%95.07K
-86.58%91.91K
--457.53K
--659.98K
--400.74K
--684.73K
Depreciation, depletion, and amortization
--0.00
--0.00
----
--0.00
--0.00
--0.00
----
--0.00
--0.00
--0.00
----
--0.00
--0.00
--0.00
----
----
----
----
----
----
----
----
Operating profit
44.94%-2.27M
50.91%-2.15M
45.61%-2.78M
9.42%-2.82M
-19.64%-4.12M
-50.81%-4.38M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.90M
-24.11%-3.26M
23.71%-3.54M
35.62%-2.62M
-81.11%-2.67M
-140.35%-2.63M
-253.14%-4.64M
-345.67%-4.07M
-15.26%-1.47M
---1.09M
---1.31M
---913.36K
---1.28M
Net non-operating interest income (expenses)
Non-operating interest income
--23.40K
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Special income (expenses)
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
----
--0.00
--0.00
--66.50K
--0.00
----
--0.00
--0.00
----
Income before tax
45.50%-2.25M
50.91%-2.15M
45.61%-2.78M
9.42%-2.82M
-19.64%-4.12M
-50.81%-4.38M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.90M
-24.11%-3.26M
23.71%-3.54M
34.55%-2.62M
-81.11%-2.67M
-140.35%-2.63M
-253.14%-4.64M
-338.39%-4.00M
-15.26%-1.47M
---1.09M
---1.31M
---913.36K
---1.28M
Income after tax
45.50%-2.25M
50.91%-2.15M
45.61%-2.78M
9.42%-2.82M
-19.64%-4.12M
-50.81%-4.38M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.90M
-24.11%-3.26M
23.71%-3.54M
34.55%-2.62M
-81.11%-2.67M
-140.35%-2.63M
-253.14%-4.64M
-338.39%-4.00M
-15.26%-1.47M
---1.09M
---1.31M
---913.36K
---1.28M
Net income from continuous operations
45.50%-2.25M
50.91%-2.15M
45.61%-2.78M
9.42%-2.82M
-19.64%-4.12M
-50.81%-4.38M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.90M
-24.11%-3.26M
23.71%-3.54M
34.55%-2.62M
-81.11%-2.67M
-140.35%-2.63M
-253.14%-4.64M
-338.39%-4.00M
-15.26%-1.47M
---1.09M
---1.31M
---913.36K
---1.28M
Net income attributable to controlling interests
45.50%-2.25M
50.91%-2.15M
45.61%-2.78M
9.42%-2.82M
-19.64%-4.12M
-50.81%-4.38M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.90M
-24.11%-3.26M
23.71%-3.54M
34.55%-2.62M
-81.11%-2.67M
-140.35%-2.63M
-253.14%-4.64M
-338.39%-4.00M
-15.26%-1.47M
---1.09M
---1.31M
---913.36K
---1.28M
Net income attributable to common shareholders
45.50%-2.25M
50.91%-2.15M
45.61%-2.78M
9.42%-2.82M
-19.64%-4.12M
-50.81%-4.38M
-56.86%-5.11M
12.05%-3.11M
-31.47%-3.45M
-8.72%-2.90M
-24.11%-3.26M
23.71%-3.54M
34.55%-2.62M
-81.11%-2.67M
-140.35%-2.63M
-253.14%-4.64M
-338.39%-4.00M
-15.26%-1.47M
---1.09M
---1.31M
---913.36K
---1.28M
Basic earnings per share
-14390.81%-37.74
-658.08%-2.15
55.54%-0.16
28.01%-0.17
7.87%-0.26
-13.45%-0.28
-31.60%-0.37
24.60%-0.24
-10.72%-0.28
4.42%-0.25
-8.79%-0.28
30.77%-0.32
55.56%-0.26
-68.87%-0.26
-373.53%-0.26
-118.75%-0.46
-275.96%-0.57
-15.26%-0.15
---0.05
---0.21
---0.15
---0.13
Diluted earnings per share
-14390.81%-37.74
-658.08%-2.15
55.54%-0.16
28.01%-0.17
7.87%-0.26
-13.45%-0.28
-31.60%-0.37
24.60%-0.24
-10.72%-0.28
4.42%-0.25
-8.79%-0.28
30.77%-0.32
55.56%-0.26
-68.87%-0.26
-373.53%-0.26
-118.75%-0.46
-275.96%-0.57
-15.26%-0.15
---0.05
---0.21
---0.15
---0.13
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
